Home › Pericardial Disorders › Minnesota
Pericardial Disorders clinical trials in Minnesota
4 studies for Pericardial Disorders are looking for participants at sites in Minnesota.
Cities in Minnesota
An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
- Mayo Clinic, Rochester
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 22, 2026 · NCT06836232CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
- Minneapolis Heart Institute, Minneapolis
- Mayo Clinic, Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06708299Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
- Investigational Site 055, Minneapolis
- Investigational Site 012, Rochester
RecruitingPhase 2/3
Ages 18 to 80 · All sexes · Updated Aug 26, 2026 · NCT07010159Transition to KPL-387 Monotherapy Dosing & Administration Study
- Investigational Site 028, Rochester
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 11, 2026 · NCT07288216From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.